We are live on ! Find out more
BBI

Baxter Bros Inc Portfolio holdings

AUM $810M
1-Year Est. Return 16.24%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+16.24%
3 Year Est. Return
+68.81%
5 Year Est. Return
+86.22%
10 Year Est. Return
+312.36%
AUM
$672M
AUM Growth
+$36.3M
Cap. Flow
+$707K
Cap. Flow %
0.11%
Top 10 Hldgs %
43.5%
Holding
136
New
2
Increased
40
Reduced
51
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 24.86%
2 Financials 23.02%
3 Industrials 12.38%
4 Communication Services 12.36%
5 Energy 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RKLB icon
126
Rocket Lab Corp
RKLB
$42.3B
$60K 0.01%
10,000
ABBV icon
127
AbbVie
ABBV
$450B
-1,345
Closed -$214K
OLED icon
128
Universal Display
OLED
$3.75B
-1,300
Closed -$202K
FRG
129
DELISTED
Franchise Group, Inc.
FRG
-22,490
Closed -$613K

Similar funds

Baxter Bros Inc's Q2 2023 Portfolio in Review

As of Q2 2023, Baxter Bros Inc held 136 positions worth $672M, up 5.7% from $636M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 3.7%. Baxter Bros Inc opened 2 new positions and exited 3, leaving the 136-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.

  • Baxter Bros Inc's largest Q2 2023 buy was Albemarle: 1,250 shares worth $279K.
  • Baxter Bros Inc added most to Freeport-McMoran in Q2 2023, an estimated $826K increase.
  • Baxter Bros Inc's biggest Q2 2023 reduction was Immunogen Inc, cutting an estimated $848K.
  • Baxter Bros Inc fully exited Franchise Group, Inc. in Q2 2023, selling an estimated $613K.
  • Baxter Bros Inc's ten largest holdings make up 43% of its $672M portfolio in Q2 2023.
  • Baxter Bros Inc opened 2 new positions and closed 3 in Q2 2023.
  • Baxter Bros Inc's portfolio value rose 5.7% quarter-over-quarter to $672M.

Based on Baxter Bros Inc's 13F filing for Q2 2023, filed 14 Aug 2023.